These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Voxel based morphometry features and follow-up of amnestic patients at high risk for Alzheimer's disease conversion. Rami L; Gómez-Anson B; Monte GC; Bosch B; Sánchez-Valle R; Molinuevo JL Int J Geriatr Psychiatry; 2009 Aug; 24(8):875-84. PubMed ID: 19259976 [TBL] [Abstract][Full Text] [Related]
6. Grey-matter atrophy in Alzheimer's disease is asymmetric but not lateralized. Derflinger S; Sorg C; Gaser C; Myers N; Arsic M; Kurz A; Zimmer C; Wohlschläger A; Mühlau M J Alzheimers Dis; 2011; 25(2):347-57. PubMed ID: 21422522 [TBL] [Abstract][Full Text] [Related]
7. Verbal episodic memory impairment in Alzheimer's disease: a combined structural and functional MRI study. Rémy F; Mirrashed F; Campbell B; Richter W Neuroimage; 2005 Mar; 25(1):253-66. PubMed ID: 15734360 [TBL] [Abstract][Full Text] [Related]
8. Morphological cerebral correlates of CERAD test performance in mild cognitive impairment and Alzheimer's disease. Dos Santos V; Thomann PA; Wüstenberg T; Seidl U; Essig M; Schröder J J Alzheimers Dis; 2011; 23(3):411-20. PubMed ID: 21116054 [TBL] [Abstract][Full Text] [Related]
9. Neural correlates of verbal episodic memory in patients with MCI and Alzheimer's disease--a VBM study. Leube DT; Weis S; Freymann K; Erb M; Jessen F; Heun R; Grodd W; Kircher TT Int J Geriatr Psychiatry; 2008 Nov; 23(11):1114-8. PubMed ID: 18449954 [TBL] [Abstract][Full Text] [Related]
10. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry. Chételat G; Fouquet M; Kalpouzos G; Denghien I; De la Sayette V; Viader F; Mézenge F; Landeau B; Baron JC; Eustache F; Desgranges B Neuropsychologia; 2008; 46(6):1721-31. PubMed ID: 18289618 [TBL] [Abstract][Full Text] [Related]
11. Constructional apraxia in Alzheimer's disease: association with occipital lobe pathology and accelerated cognitive decline. Smith MZ; Esiri MM; Barnetson L; King E; Nagy Z Dement Geriatr Cogn Disord; 2001; 12(4):281-8. PubMed ID: 11351139 [TBL] [Abstract][Full Text] [Related]
12. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile. Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769 [TBL] [Abstract][Full Text] [Related]
13. Early-onset and late-onset Alzheimer's disease are associated with distinct patterns of memory impairment. Joubert S; Gour N; Guedj E; Didic M; Guériot C; Koric L; Ranjeva JP; Felician O; Guye M; Ceccaldi M Cortex; 2016 Jan; 74():217-32. PubMed ID: 26694580 [TBL] [Abstract][Full Text] [Related]
14. The cognitive and neural expression of semantic memory impairment in mild cognitive impairment and early Alzheimer's disease. Joubert S; Brambati SM; Ansado J; Barbeau EJ; Felician O; Didic M; Lacombe J; Goldstein R; Chayer C; Kergoat MJ Neuropsychologia; 2010 Mar; 48(4):978-88. PubMed ID: 19954747 [TBL] [Abstract][Full Text] [Related]
15. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Chételat G; Landeau B; Eustache F; Mézenge F; Viader F; de la Sayette V; Desgranges B; Baron JC Neuroimage; 2005 Oct; 27(4):934-46. PubMed ID: 15979341 [TBL] [Abstract][Full Text] [Related]
16. Are the behavioral symptoms of Alzheimer's disease directly associated with neurodegeneration? Serra L; Perri R; Cercignani M; Spanò B; Fadda L; Marra C; Carlesimo GA; Caltagirone C; Bozzali M J Alzheimers Dis; 2010; 21(2):627-39. PubMed ID: 20555138 [TBL] [Abstract][Full Text] [Related]
17. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice]. Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552 [TBL] [Abstract][Full Text] [Related]
18. Montreal cognitive assessment in assessing clinical severity and white matter hyperintensity in Alzheimer's disease with normal control comparison. Chang YT; Chang CC; Lin HS; Huang CW; Chang WN; Lui CC; Lee CC; Lin YT; Chen CH; Chen NC Acta Neurol Taiwan; 2012 Jun; 21(2):64-73. PubMed ID: 22879115 [TBL] [Abstract][Full Text] [Related]
19. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia. Doddy RS; Massman PJ; Mawad M; Nance M Neuropsychiatry Neuropsychol Behav Neurol; 1998 Oct; 11(4):191-9. PubMed ID: 9845410 [TBL] [Abstract][Full Text] [Related]
20. Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis. Tur C; Penny S; Khaleeli Z; Altmann DR; Cipolotti L; Ron M; Thompson AJ; Ciccarelli O Mult Scler; 2011 Nov; 17(11):1324-32. PubMed ID: 21803874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]